Beijing Winsunny Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005QF9
CNY
15.64
-0.99 (-5.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,477.37
3,420.91
3,313.23
3,212.52
2,815.19
2,535.35
2,424.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,477.37
3,420.91
3,313.23
3,212.52
2,815.19
2,535.35
2,424.68
Raw Material Cost
1,252.33
1,166.79
1,150.47
1,061.85
887.87
749.60
608.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
338.95
343.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.89
3.63
5.54
5.01
9.78
11.84
14.36
Selling and Distribution Expenses
1,330.81
1,378.05
1,334.17
1,475.10
1,385.23
1,328.77
1,383.86
Other Expenses
37.98
39.62
32.79
22.06
15.95
-21.97
-19.58
Total Expenditure (Excl Depreciation)
2,964.78
2,944.70
2,818.06
2,762.58
2,442.42
2,209.51
2,154.17
Operating Profit (PBDIT) excl Other Income
512.6
476.2
495.20000000000005
449.90000000000003
372.8
325.79999999999995
270.5
Other Income
34.76
74.24
72.41
59.48
14.33
15.57
19.28
Operating Profit (PBDIT)
662.86
649.41
658.50
573.89
432.91
359.67
308.38
Interest
1.89
3.63
5.54
5.01
9.78
11.84
14.36
Exceptional Items
0.01
1.50
0.98
1.16
6.05
1.40
1.51
Gross Profit (PBDT)
2,225.04
2,254.12
2,162.76
2,150.67
1,927.32
1,785.75
1,816.12
Depreciation
137.64
107.15
104.79
84.09
63.48
49.45
48.66
Profit Before Tax
523.34
540.12
549.15
485.95
365.69
299.78
246.87
Tax
52.08
48.04
56.81
46.33
49.79
35.28
26.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
469.36
488.67
488.77
438.90
314.47
262.71
218.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
469.36
488.67
488.77
438.90
314.47
262.71
218.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.90
3.40
3.57
0.72
1.44
1.79
1.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
471.26
492.08
492.34
439.62
315.91
264.50
220.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,779.34
3,544.56
3,468.42
3,174.41
1,211.49
1,005.29
847.83
Earnings per share (EPS)
1.0
1.04
1.02
0.91
0.66
0.55
0.46
Diluted Earnings per share
1.0
1.04
1.02
0.91
0.66
0.55
0.46
Operating Profit Margin (Excl OI)
14.1%
13.68%
14.53%
13.39%
12.61%
11.62%
9.92%
Gross Profit Margin
19.01%
18.92%
19.74%
17.74%
15.24%
13.77%
12.19%
PAT Margin
13.5%
14.28%
14.75%
13.66%
11.17%
10.36%
9.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 1.65% vs 3.25% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -4.23% vs -0.04% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 9.20% vs -1.86% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -47.22% vs -34.55% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Beijing Winsunny Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,477.37
0
3,477.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,477.37
0
3,477.37
Raw Material Cost
1,252.33
0
1,252.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.89
0
1.89
Selling and Distribution Expenses
1,330.81
0
1,330.81
Other Expenses
37.98
0.00
37.98
Total Expenditure (Excl Depreciation)
2,964.78
0
2,964.78
Operating Profit (PBDIT) excl Other Income
512.58
0.00
512.58
Other Income
34.76
0
34.76
Operating Profit (PBDIT)
662.86
0
662.86
Interest
1.89
0
1.89
Exceptional Items
0.01
0
0.01
Gross Profit (PBDT)
2,225.04
0
2,225.04
Depreciation
137.64
0
137.64
Profit Before Tax
523.34
0
523.34
Tax
52.08
0
52.08
Provisions and contingencies
0
0
0.00
Profit After Tax
469.36
0
469.36
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
469.36
0
469.36
Share in Profit of Associates
0
0
0.00
Minority Interest
1.90
0
1.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
471.26
0
471.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,779.34
0
3,779.34
Earnings per share (EPS)
1.00
0
1.00
Diluted Earnings per share
1.00
0
1.00
Operating Profit Margin (Excl OI)
14.10%
0%
0.00
14.10%
Gross Profit Margin
19.01%
0%
0.00
19.01%
PAT Margin
13.50%
0%
0.00
13.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 347.74 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 1.65% vs 3.25% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 47.13 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.23% vs -0.04% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 62.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 9.20% vs -1.86% in Dec 2024

Annual - Interest
Interest 0.19 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -47.22% vs -34.55% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.10%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024